This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignees: Acucela Inc., Merck Sharp + Dohme Corp.. Active years: 2013-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2019
Title: The Innovator Spotlight: Lana Michele Rossiter
Introduction:
Lana Michele Rossiter, a brilliant inventor hailing from Clifton Park, NY, is making significant strides in the field of ophthalmic treatments. With a total of 5 patents under her belt, Lana's innovative work is transforming the way we approach neurodegenerative diseases and disorders, particularly in the realm of ophthalmology.
Latest Patents:
Lana's latest patents focus on styrenyl derivative compounds for the treatment of various ophthalmic diseases and disorders. These compounds, including stilbene derivative compounds, show promise in combatting conditions such as age-related macular degeneration (AMD) and Stargardt's Disease. Her inventive compositions and methods offer new hope for patients affected by these challenging conditions.
Career Highlights:
Throughout her career, Lana has made significant contributions to the field of ophthalmic research. Having worked at renowned companies such as Acucela Inc. and Merck Sharp & Dohme Corporation, she has been at the forefront of developing innovative treatments for neurodegenerative diseases. Lana's dedication to improving patient outcomes is evident in the impact of her pioneering work.
Collaborations:
In her pursuit of excellence, Lana has collaborated with esteemed colleagues such as Ian L Scott and Anna S Gall. Together, they have formed a dynamic team that is committed to pushing the boundaries of ophthalmic research. Through these collaborations, Lana has been able to leverage diverse perspectives and expertise to drive forward groundbreaking innovations in the field.
Conclusion:
In conclusion, Lana Michele Rossiter's innovative spirit and dedication to advancing ophthalmic treatments make her a standout inventor in the field. Her exploration of styrenyl derivative compounds and their potential in treating ophthalmic diseases and disorders is paving the way for new possibilities in the realm of neurodegenerative disease research. With a bright future ahead, Lana continues to inspire with her inventive solutions and unwavering commitment to improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile